DRKS00032849SuspendedNot Applicable
Establishment of an immune monitoring for the prevention ofrejection and infections after kidney transplantation
ierenzentrum Heidelberg0 sites500 target enrollmentStarted: October 12, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Suspended
- Sponsor
- Enrollment
- 500
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Kidney transplanted patients at the Heidelberg Kidney Center between 01.01.2017 and 31.12.2021
Exclusion Criteria
- •Failure to meet inclusion critera
Investigators
Similar Trials
Active, not recruiting
Phase 1
Monitoring response on COVID-19 vaccination in children with cancerChildren with cancer, receiving COVID-19 vaccinationEUCTR2021-003388-90-NLPrincess Máxima Center for Pediatric Oncology130
Completed
Phase 4
Prospective monitoring of immune response following COVID-19 vaccination in children with cancerNL-OMON52106Prinses Máxima Centrum voor Kinderoncologie130
Active, not recruiting
Phase 1
Effectivity of COVID-19 vaccination in people with Down syndromeEUCTR2021-002613-34-NLniversity Medical Center Utrecht640
Recruiting
Phase 4
Prospective monitoring of antibody response following COVID-19 vaccination in patients with Down syndromeNL-OMON54387niversitair Medisch Centrum Utrecht640
Recruiting
Not Applicable
Monitoring of the *healthy* immune response in the sentinel lymph node of patients undergoing a prophylactic mastectomy.Breastcancermammacarcinoma10006291NL-OMON36250Antoni van Leeuwenhoek Ziekenhuis20